In a significant development, Medicana Health Group is poised to extend its acclaimed healthcare services to the UK, targeting the increasing demand for premium healthcare offerings.
As an authority in comprehensive healthcare provision, Medicana Health Group is making strides into the UK, introducing its lauded patient-first philosophy and bespoke treatment options. This move is a calculated response to the growing trend towards private healthcare and insurance following the global COVID pandemic. Medicana’s core principle revolves around “active listening and personalised attention,” with a focus on understanding and catering to the individual needs of each patient, thus promising a customised healthcare experience from the initial consultation to the aftercare, with the aim of setting new standards in UK private healthcare.
With a steadfast commitment to “active listening and personalised attention at every stage of the patient’s journey,” Medicana Health Group is dedicated to offering a patient experience that is not only deeply personalised but also carefully curated, reflecting their proven approach in Türkiye to innovate private healthcare in the UK.
Navigating the £282 Billion UK Healthcare Market
The post-COVID revival of the UK’s private healthcare sector has seen a significant boost from individuals opting for self-payment options. A record number of people are choosing private healthcare to circumvent the long waiting periods of the NHS and to benefit from the quality and expertise of the independent sector. According to an Akeso report, the UK’s healthcare spending in 2022 was estimated at £282 billion, with public spending constituting around 80% and private expenditure about 20%.
With this emerging market opportunity, Medicana is set to harness its extensive expertise and wide array of care services to venture into the UK’s private healthcare landscape. By implementing its validated healthcare model, which spans comprehensive diagnostics to custom treatments, Medicana is equipped to address the growing demand for exceptional private healthcare. The group’s allegiance to superior care, paired with its innovative approach to patient management, positions Medicana as a fitting response to the UK’s healthcare requirements.
Attending to 5.5 Million Patients Every Year
Medicana Health Group annually serves over 5.5 million patients globally, through its 16 hospitals equipped with ample bed capacity. This evidences their extensive experience in premium healthcare provision and their ability to accommodate the complex needs of an international patient cohort. Medicana Health Group’s entry into the UK market is poised to effect a significant shift towards more empathetic, effective, and individualised healthcare, signifying a pivotal moment in their mission to improve patient welfare and elevate global healthcare standards.
With more than 30 years of operational experience, Medicana’s medical expertise encompasses a diverse range of specialities, offering state-of-the-art services in areas such as Oncology, Surgical Oncology, Organ and Bone Marrow Transplantation, Neurosurgery, In Vitro Fertilisation (IVF), Genetics, Cardiovascular Surgery, Orthopaedics and Traumatology, and Obesity Surgery. Since 2016, Medicana Health Group has also expanded into education, offering an extensive selection of educational programmes from early childhood to higher education, both locally in Türkiye and abroad.
Leave a Reply